These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16768629)

  • 1. Adjunctive quetiapine targets self-harm behaviors in adolescent females with major depressive disorder.
    Good CR
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):235-6. PubMed ID: 16768629
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder.
    Frey BN; Haber E; Mendes GC; Steiner M; Soares CN
    Arch Womens Ment Health; 2013 Feb; 16(1):83-5. PubMed ID: 23143411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine of non-suicidal self-injury associated with dysphoric mania and ultradian cycling bipolar disorder.
    Novis F; Silva AC; Nardi AE; Cheniaux E
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E61-2. PubMed ID: 24026749
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombocytopenia secondary to the use of quetiapine.
    Handoo I; Perales M; Klaus N; Khan AY
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):453-5. PubMed ID: 20973718
    [No Abstract]   [Full Text] [Related]  

  • 5. Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcome.
    Leitner I; Praschak-Rieder N; Willeit M; Kasper S
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):199-200. PubMed ID: 12890313
    [No Abstract]   [Full Text] [Related]  

  • 6. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
    Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
    J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study.
    Robert S; Hamner MB; Kose S; Ulmer HG; Deitsch SE; Lorberbaum JP
    J Clin Psychopharmacol; 2005 Aug; 25(4):387-8. PubMed ID: 16012285
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
    Sheehan DV; Locklear J; Svedsäter H; Datto C
    Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA panel issues mixed decision on quetiapine in depression and anxiety.
    Kuehn BM
    JAMA; 2009 May; 301(20):2081-2. PubMed ID: 19470978
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events.
    Jeste DV; Jin H; Golshan S; Mudaliar S; Glorioso D; Fellows I; Kraemer H; Arndt S
    Am J Psychiatry; 2009 Aug; 166(8):937-8. PubMed ID: 19651757
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
    Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
    J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-associated weight gain.
    Gentile S
    Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis.
    Catapano-Friedman L
    J Child Adolesc Psychopharmacol; 2001; 11(2):205-6. PubMed ID: 11436963
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
    Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
    Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
    Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine resolves psychotic depression in an adolescent boy.
    Padla D
    J Child Adolesc Psychopharmacol; 2001; 11(2):207-8. PubMed ID: 11436964
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
    Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
    Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y; Guo Z; Kalsekar I; Forbes RA; Hebden T; Thase ME
    Int Clin Psychopharmacol; 2013 Mar; 28(2):87-90. PubMed ID: 23262644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.